(Q41294797)

29 September 2017

title

The clinical features of patients with a Y93H variant of hepatitis C virus detected by a PCR invader assay (English)

1 reference

29 September 2017

1 reference

1 reference

Toshiki Kan

1

1 reference

29 September 2017

Senju Hashimoto

2

1 reference

29 September 2017

Naoto Kawabe

3

1 reference

29 September 2017

Michihito Murao

4

1 reference

29 September 2017

Takuji Nakano

5

1 reference

29 September 2017

Hiroaki Shimazaki

6

1 reference

29 September 2017

Kazunori Nakaoka

7

1 reference

29 September 2017

Masashi Ohki

8

1 reference

29 September 2017

Yuka Takagawa

9

1 reference

29 September 2017

Takamitsu Kurashita

10

1 reference

29 September 2017

Tomoki Takamura

11

1 reference

29 September 2017

Kentaro Yoshioka

12

1 reference

29 September 2017

language of work or name

1 reference

24 April 2015

1 reference

Journal of Gastroenterology

29 September 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

29 September 2017

volume

51

1 reference

29 September 2017

issue

1

1 reference

29 September 2017

page(s)

63-70

1 reference

Global epidemiology of hepatitis C virus infection

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1080-1

Optimal IFN-free therapy in treatment-naïve patients with HCV genotype 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1080-1

Rapid loss of hepatitis C virus genotype 1b from serum in patients receiving a triple treatment with telaprevir (MP-424), pegylated interferon and ribavirin for 12 weeks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1080-1

Phase III results of Boceprevir in treatment naïve patients with chronic hepatitis C genotype 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1080-1

Once-daily simeprevir (TMC435) with peginterferon/ribavirin for treatment-naïve hepatitis C genotype 1-infected patients in Japan: the DRAGON study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1080-1

Vaniprevir plus peginterferon alfa-2a and ribavirin in treatment-experienced Japanese patients with hepatitis C virus genotype 1 infection: a randomized phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1080-1

Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1080-1

Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1080-1

HCV cirrhosis at the edge of decompensation: will paritaprevir with ritonavir, ombitasvir, dasabuvir, and ribavirin solve the need for treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1080-1

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1080-1

Sequence variation in hepatitis C virus nonstructural protein 5A predicts clinical outcome of pegylated interferon/ribavirin combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1080-1

Factors correlating with acoustic radiation force impulse elastography in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1080-1

Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 1b high viral load and non-virological response to interferon-ribavirin combination therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1080-1

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1080-1

Naturally occurring, resistance-associated hepatitis C virus NS5A variants are linked to interleukin-28B genotype and are sensitive to interferon-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1080-1

A novel simple assay system to quantify the percent HCV-RNA levels of NS5A Y93H mutant strains and Y93 wild-type strains relative to the total HCV-RNA levels to determine the indication for antiviral therapy with NS5A inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1080-1

Deep sequencing analysis of variants resistant to the non-structural 5A inhibitor daclatasvir in patients with genotype 1b hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1080-1

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1080-1

Baseline factors and very early viral response (week 1) for predicting sustained virological response in telaprevir-based triple combination therapy for Japanese genotype 1b chronic hepatitis C patients: a multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1080-1

Factors predictive of sustained virological response following 72 weeks of combination therapy for genotype 1b hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1080-1

Hepatitis C virus NS5A protein interacts with 2',5'-oligoadenylate synthetase and inhibits antiviral activity of IFN in an IFN sensitivity-determining region-independent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1080-1

Proteomic approach identifies HSP27 as an interacting partner of the hepatitis C virus NS5A protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1080-1

Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1080-1

Hepatitis C virus NS5A drives a PTEN-PI3K/Akt feedback loop to support cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1080-1

Fibrosis and disease progression in hepatitis C.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25904097

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25904097

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00535-015-1080-1

1 reference

29 September 2017

1 reference